A

Alderley Park Ventures

0 employees

Alderley Park Ventures is a £5M seed investment fund managed by BioCity following a significant contribution by AstraZeneca.

Investor insights

Sectors invested in

Pharmaceutical2

Biotechnology2

Biopharma2

Oncology2

POM to P1

Reclassification1

P to GSL1

Health Care1

Switch1

Rx to OTC1

Consultancy1

Capability1

OTC Medicines Commercialisation1

Self Care1

Innovation1

OTC1

Life Science1

Therapeutics1

Medical1

E-Learning1

Funding rounds participated in

$4.4M sweet spot round size

Most of their 5 investments are in rounds between $339K and $4.4M

Investor type

Venture Capital

Basic info

Industry

investment banking

Sectors

Financial Services

Finance

Banking

Date founded

2014

Investments made

M

MAXWELLIA raised $4.4M on April 8, 2021

Investors: Praetura Ventures, BioCity Nottingham and Alderley Park Ventures

K

Kinomica raised $5.2M on December 14, 2020

Investors: LONGWALL VENTURE PARTNERS LLP, PUFFIN POINT, BioCity Nottingham and Alderley Park Ventures

B

BiVictriX Therapeutics Ltd raised undisclosed on August 19, 2019

Investors: Development Bank of Wales and Alderley Park Ventures

S

Surgicalteaching.com raised undisclosed on August 2, 2018

Investors: Greater Manchester and Cheshire Life Sciences Fund and Alderley Park Ventures

U

Undisclosed raised $339K on November 23, 2017